Please Wait
Applying Filters...
menu
    • menu
    DRL-PSE
    News
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology

    03 Apr 2019

    // ECONOMIC TIMES

    Promius promotes digital campaign to empower skin condition patients

    05 Nov 2018

    // Beth Snyder Bulik FIERCE PHARMA

    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco

    23 May 2018

    // PATENT LITIGATION

    Data Compilation
    #PharmaFlow

    Dr Reddy Promius Pharma RM

    Contact Supplier

    Website

    BioAsia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Menu

    Promius Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Promius Pharma, LLC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    arrow
    PharmScience R&D
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2019-10-16

    Promius Pharma

    City : Princeton

    State : NJ

    Country/Area : US

    Zip : 08540-6623

    District : NWJ

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2019-10-16

    Dr. Reddy Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow